Tradestie Institutional Equity Comparison Engine

AQST vs AYTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin, Options & Structure while AQST counters with relative strength in Momentum & Technical. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, AQST sits in BREAKDOWN (40th %ile IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
AQST N/M vs AYTU 9.2x Fwd P/E
Growth & Margin Winner AYTU
Op Margin -114.1% vs -14.4% ยท YoY -41.0% vs +6.4%
Momentum & Technical Winner AQST
1Y -28.8% vs -12.1% ยท 52W Pos 22% vs 5%
Options & Structure Winner AYTU
BREAKDOWN (40th %ile IV) vs UNCLASSIFIED (N/A IV)
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.77
-3.45% 1D
Market Cap $448.7M
1M Return -0.13%
1Y Return -28.77%
Forward P/E N/M
Unified AI Score
59.4 / 100 HOLD
Tech 69.0 Fund 66.0 Flow 71.0 Mom 54.0
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AQST -28.77% AYTU -12.14% Spread: +16.63 pp (AYTU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AQST Revenue AYTU Revenue AQST Op. Margin AYTU Op. Margin Margin Edge
FY2019 $50M $10M -100.1% -230.1% AQST
FY2020 $50M $30M -93.6% -76.5% AYTU
FY2021 $50M $70M -68.2% -89.7% AQST
FY2022 $50M $100M -88.2% -113.7% AQST
FY2023 $50M $110M -29.9% -15.9% AYTU
FY2024 $60M $70M -53.5% -2.4% AYTU
FY2025 $40M $70M -159.5% -11.8% AYTU
FY2026 N/A $60M N/A -14.4% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AQST (4) vs AYTU (6)
Institutional Metric AQST AYTU Criterion Row Winner
Market Capitalization Scale $448.7M $19.6M Larger Scale AQST
Trailing P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Forward P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Revenue Growth (YoY) Growth -41.0% +6.4% Higher Growth AYTU
Operating Margin (TTM) Profitability -114.1% -14.4% Higher Margin AYTU
Net Profit Margin Profitability -162.3% -24.8% Higher Margin AYTU
Return on Equity (ROE) Capital Efficiency 0.0% -52.5% Higher ROE AQST
52-Week Range Position Momentum 22% ($3โ€“$7) 5% ($2โ€“$3) Stronger Trend AQST
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 56% Vol 0.65ฮฒ ยท 35% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 59.4 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite AQST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AQST vs AYTU Buy Guide
AQST BREAKDOWN
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 40th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AQST nor AYTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.